More News! 13 Feb 2017To the Rescue: A Final Phase III Success for Post-Operative Nausea The dopamine antagonist Baremsis is on its way to FDA approval for the treatment and prophylaxis of post-operative nausea & vomiting, after… February 13, 2017 - 3 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
Best in Biotech 30 Jan 2017The Shiniest Golden Vertex? 15 Great Biotechs in Cambridge Cambridge's image is tied to its Hogwarts-like University and Nobel-hoarding academia, but there's also an exciting entrepreneurial scene at the… January 30, 2017 - 8 minutesmins - By Denise Neves Gameiro Share WhatsApp Twitter Linkedin Email
News and Trends 5 Jan 2016Say Goodbye to Post-Operation Nausea with this Phase III UK Trial Success An anti-vomiting medication for post-operative patients has smashed its phase III trial in the UK in one of the largest… January 5, 2016 - 3 minutesmins - By Dani Bancroft Share WhatsApp Twitter Linkedin Email
News and Trends 26 Oct 2015Financial Storm approaching? EU Biotechs start postponing their IPOs in London … Biotech financing beats record over record since beginning of 2014. Financing has never been as high in Europe (though of… October 26, 2015 - 3 minutesmins - By Philip Hemme Share WhatsApp Twitter Linkedin Email